Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,217
Ph III recruiting: 128
Growth YoY: +13.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (886)

clinicaltrialsPublishedShowing 651–700 of 1,534 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07405476	Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment	recruiting	Phase 2	38	Emory UniversityOTHER	1	Apr 17, 2026	clinicaltrials
NCT03259867	Combination of TATE and PD-1 Inhibitor in Liver Cancer(TATE-PD1)	recruiting	Phase 2	54	Teclison Ltd.INDUSTRY	1	Apr 16, 2026	clinicaltrials